PGAM1-IN-1 is primarily used in research settings to study its inhibitory effects on the enzyme phosphoglycerate mutase 1 (PGAM1). This enzyme plays a critical role in glycolysis and biosynthesis pathways, making it a potential target for cancer therapy. Researchers utilize PGAM1-IN-1 to investigate its ability to disrupt cancer cell metabolism, potentially slowing tumor growth. It is also employed in studies exploring metabolic reprogramming in various diseases, providing insights into novel therapeutic strategies. Additionally, PGAM1-IN-1 serves as a tool compound to better understand the role of PGAM1 in cellular processes and its implications in metabolic disorders.